N-octanoyl-dopamine is a potent inhibitor of platelet function

Platelets

Volumn 24, Issue 6, 2013, Pages 428-434

  Ait Hsiko, Lamia ^a   Kraaij, Tineke ^a   Wedel, Johannes ^a   Theisinger, Bastian ^b   Theisinger, Sonja ^b   Yard, Benito ^a   Bugert, Peter ^a   Schedel, Angelika ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NOVALIQ GMBH   (Germany)

Author keywords

Dopamine agonism; N octanoyl dopamine; Platelet activation; Platelet inhibition; Redox activity

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CD63 ANTIGEN; CYCLIC AMP; DOPAMINE; DOPAMINE DERIVATIVE; DUAL SPECIFICITY PHOSPHATASE 2; ESTERASE; N OCTANOYL DOPAMINE; N OCTANOYL TYRAMINE; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TEST; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NORMAL HUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER;

EID: 84880914873     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.715217     Document Type: Article

References (35)

1. Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998;65(12):1533-1542.
2. Hing A, Hicks M, Gao L, Wilson M, Mackie F, Macdonald PS. The case for a standardised protocol that includes hormone resuscitation for the management of the cadaveric multi-organ donor. Crit Care Resusc 2005;7(1):43-50.
3. Kotsch K, Ulrich F, Reutzel-Selke A, Pascher A, Faber W, Warnick P, Hoffman S, Francuski M, Kunert C, Kuecuek O, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: A prospective randomized controlled trial. Ann Surg 2008;248(6):1042-1050.
4. Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, Munari M, Boifava S, Cornara G, Della Corte F, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: A randomized controlled trial. JAMA 2010;304(23):2620-2627.
5. Schnuelle P, Yard BA, Braun C, Dominguez-Fernandez E, Schaub M, Birck R, Sturm J, Post S, van der Woude FJ. Impact of donor dopamine on immediate graft function after kidney transplantation. Am J Transplant 2004;4(3):419-26.
6. Gottmann U, Notheisen A, Brinkkoetter PT, Yard BA, Waldherr R, Schnuelle P, van der Woude FJ, Braun C. Influence of donor pretreatment with dopamine on allogeneic kidney transplantation after prolonged cold storage in rats. Transplantation 2005;79(10):1344-1350.
7. Gottmann U, Notheisen A, Brinkkoetter PT, Yard BA, Waldherr R, Schnuelle P, van der Woude FJ, Braun C. Effects of donor pre-treatment with dopamine on graft function after kidney transplantation: A randomized controlled trial. JAMA 2009;302(10):1067-1075.
8. Benck U, Hoeger S, Brinkkoetter PT, Gottmann U, Doenmez D, Boesebeck D, Lauchart W, Gummert J, Karck M, Lehmkuhl HB, et al. Effects of donor pre-treatment with dopamine on survival after heart transplantation: A cohort study of heart transplant recipients nested in a randomized controlled multicenter trial. J Am Coll Cardiol 2011;58(17):1768-1777.
9. Brinkkoetter PT, Song H, Lösel R, Schnetzke U, Gottmann U, Feng Y, Hanusch C, Beck GC, Schnuelle P, Wehling M, et al. Hypothermic injury: The mitochondrial calcium, ATP and ROS love-hate triangle out of balance. Cell Physiol Biochem 2008;22(1-4):195-204.
10. Hoeger S, Reisenbuechler A, Gottmann U, Doyon F, Braun C, Kaya Z, Seelen MA, van Son WJ, Waldherr R, Schnuelle P, et al. Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation. Transpl Int 2008;21(11):1072-80.
11. Cywes R, Mullen JB, Stratis MA, Greig PD, Levy GA, Harvey PR, Strasberg SM. Prediction of the outcome of transplantation in man by platelet adherence in donor liver allografts. Evidence of the importance of prepreservation injury. Transplantation 1993;56(2):316-323.
12. Laskowski I, Pratschke J, Wilhelm MJ, Gasser M, Tilney NL. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 2000;5(4):29-35.
13. Koo DD, Welsh KI, Roake JA, Morris PJ, Fuggle SV. Ischemia/reperfusion injury in human kidney transplantation: An immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998;153(2):557-566.
14. Anfossi G, Trovati M. Role of catecholamines in platelet function: Pathophysiological and clinical significance. Eur J Clin Invest 1996;26(5):353-370.
15. De Keyser J, De Waele M, Convents A, Ebinger G, Vauquelin G. Identification of D1-like dopamine receptors on human blood platelets. Life Sci 1988;42(18):1797-1806.
16. Khanna AS, Agrawal AK, Seth PK. 3H-spiroperidol binding sites in blood platelets. Biochem Biophys Res Commun 1987;146:983-988.
17. Schedel A, Schloss P, Klueter H, Bugert P. The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors. Naunyn Schmiedebergs Arch Pharmacol 2008;378:431-439.
18. Ardlie NG, Glew G, Schwartz CJ. Influence of catecholamines on nucleotide-induced platelet aggregation. Nature 1966;212(5060):415-417.
19. Emerson M, Paul W, Page CP. Regulation of platelet function by catecholamines in the cerebral vasculature of the rabbit. Br J Pharmacol 1999;27(7):1652-1656.
20. Lösel RM, Schnetzke U, Brinkkoetter PT, Song H, Beck G, Schnuelle P, Höger S, Wehling M, Yard BA. N-octanoyl dopamine, a non-hemodyanic dopamine derivative, for cell protection during hypothermic organ preservation. PLoS One 2010;5(3):e9713.
21. Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001;62(9):1153-1161.
22. Kerry R, Scrutton MC. Platelet beta-adrenoceptors. Br J Pharmacol 1983;79(3):681-691.
23. Sibley DR, Monsma Jr. FJ. Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992;13(2):61-69.
24. Del Principe D, Frega G, Savini I, Catani MV, Rossi A, Avigliano L. The plasma membrane redox system in human platelet functions and platelet-leukocyte interactions. Thromb Haemost 2009;101(2):284-289.
25. Freedman JE. Oxidative Stress and Platelets. Arterioscler Thromb Vasc Biol 2008;28:s11-16.
26. Arthur JF, Qiao J, Shen Y, Davis AK, Dunne E, Berndt MC, Gardiner EE, Andrews RK. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Sykdependent and -independent pathways. J Thromb Haemost 2012;10:1133-1141.
27. Clutton P, Miermont A, Freedman JE. Regulation of endogenous reactive oxygen species in platelets can reverse aggregation. Arterioscler Thromb Vasc Biol 2004;24(1):187-192.
28. Begonja AJ, Gambaryan S, Geiger J, Aktas B, Pozgajova M, Nieswandt B, Walter U. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood 2005;106(8):2757-2760.
29. Krötz F, Sohn HY, Pohl U. Reactive oxygen species: Players in the platelet game. Arterioscler Thromb Vasc Biol 2004;24:1988-1996.
30. Krötz F, Sohn HY, Keller M, Gloe T, Bolz SS, Becker BF, Pohl U. Depolarization of endothelial cells enhances platelet aggregation through oxidative inactivation of endothelial NTPDase. Arterioscler Thromb Vasc Biol 2002;22(12):2003-2009.
31. Pignatelli P, Pulcinelli FM, Celestini A, Lenti L, Ghiselli A, Gazzaniga PP, Violi F. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 2000;72(5):1150-1155.
32. Juste RN, Moran L, Hooper J, Soni N. Dopmaine clearance in critically ill patients. Intensive Care Med 1998;24:1217-1220.
33. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, French PA, Dauerman HL, Becker RC. Platelet functions beyond hemostasis. J Thromb Haemost 2009;7(11):1759-1766.
34. Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, Messmer K. Platelet-endothelial cell interactions during ischemia/reperfusion: The role of P-selectin. Blood 1998;92(2):507-515.
35. Kirk AD, Morell CN, Baldwin WM 3rd. Platelets influence vascularised organ transplants from start to finish. Am J Transplant 2009;9:14-22.